Stéphane Bancel: “The upside was changing hum...

In this bonus episode of Math & Magic, we’re highlighting more of our favorite marketing stories — and they aren’t stories about when success came easily. Hear from Happy Baby Organics founder Shazi Visram, IBM Chief Global Affairs Officer Jonathan Adashek, Capital One Chief Bran ...  Show more

Through the many seasons of Math & Magic, we’ve heard from dozens of brilliant creative minds about the importance of authenticity. In this bonus episode, we’re highlighting some of our best marketing stories and how staying true to yourself can lead to not only a better life, bu ...  Show more

If you're launching a moonshot, success depends on how you manage the trajectory of risk. When Stéphane Bancel became Moderna's first CEO, the biotech start-up was chasing a way-out idea many experts thought was impossible. Stéphane built a culture of calculated risk-taking to cr ...  Show more

In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a w ...  Show more

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information. 

Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.See ...  Show more